Thoracic involvement in Erdheim-Chester disease: computed tomography imaging findings and their association with the BRAF<sup>V600E</sup> mutation.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 29736852.
- Also identified by DOI 10.1007/s00330-018-5421-3.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To investigate the computed tomography (CT) thoracic findings in Erdheim-Chester disease (ECD) and evaluate the association of these findings with the BRAF<sup>V600E</sup> mutation. This was a prospective study of patients with ECD (n=61, men=46) who underwent thoracic CT imaging. CT examinations were independently interpreted by two experienced radiologists. Association of imaging findings with BRAF<sup>V600E</sup> was achieved via the Chi-square or Fisher's exact test and odds ratios (OR) with 95% confidence intervals (CI), as appropriate. Fifty-five ECD patients (90%) showed pulmonary findings, which included interlobular septal thickening (69%), pulmonary nodules (62%), airway thickening (13%) and ground glass opacities (36%). Pulmonary nodules were classified by the pattern of distribution: subpleural regions (36%), lung parenchyma (13%) and both regions (13%). Pleural and mediastinal involvement were present in 15% and 62% of cases, respectively. The most common mediastinal finding was sheathing of the right coronary artery (34%), followed by sheathing of the thoracic aorta (30%). The BRAF<sup>V600E</sup> mutation, positive in 31 patients, was associated with the frequency of sheathing of the coronary arteries (p = 0.01). Of the thoracic findings reported in this study, we found a statistically significant positive association between the BRAF<sup>V600E</sup> mutation and presence of coronary artery sheathing. • To assess the degree of thoracic involvement in ECD with CT. • BRAF <sup>V600E</sup> mutation has a high association with right coronary artery sheathing. • BRAF <sup>V600E</sup> genetic testing detects patients at high risk of developing RCA sheathing.
Medical subject headings
- Erdheim-Chester Disease
- Proto-Oncogene Proteins B-raf
- Thorax